OMéDIT PACA-Corse

What OMéDIT PACA-Corse does

OMéDIT PACA-Corse is a French public health observatory (établissement public) operating as an inter-regional structure under the Agence Régionale de Santé PACA (ARS PACA) and ARS Corse. Founded in 2000 as OMIT (Observatoire du Médicament et de l'Innovation Thérapeutique) at the initiative of Professor Jean-Paul Cano, it was renamed OMÉDIT in 2005 and formalized under Decree No. 2017-1483 of October 18, 2017, adapting its missions to CAQES contracts and RREVA frameworks. The organization is staffed by a coordination team of approximately five pharmacists and an epidemiologist (Pr. Stéphane Honoré as Pharmacien responsable, Dr. Davy Beauger as epidemiologist/PMSI expert, Dr. Valérie Minetti at ARS PACA, Dr. Romain Arini at ARS Corse, and Dr. Marina Rebroyin as specialist assistant), with headquarters at 132 Boulevard de Paris, 13003 Marseille and a secondary site at ARS Corse in Ajaccio.

Its core deliverables are professional information and training resources rather than commercial products: the Newsletter OMéDIT (12 editions since 2015), Flash Infos bulletins, the Formations modules (notably Conciliation Médicamenteuse), the annual Journées de Pharmacie Clinique en Oncologie (JPCO), the Web Série DMI on medical device traceability, annual Fiches de Bon Usage des Médicaments, the CEPPIM iatrogenic risk evaluation framework, and the Prix OMÉDIT award program. Distribution channels include the website (omeditpacacorse.fr, hosted by MIPIH with GIP Innovation e-santé Sud), email newsletters, LinkedIn and Twitter accounts, in-person scientific congresses, and webinar/web-series formats. The technology stack is a content-publishing and coordination platform — there is no proprietary software product, API, or AI/ML system.

OMéDIT PACA-Corse does not generate commercial revenue. As a public establishment under the DPRS of ARS PACA, it is funded through public institutional budgets and provides all information, training, and support services free of charge to its constituents: healthcare establishments (ES), social and medical-social establishments (ESMS), and individual healthcare professionals across the PACA and Corsica regions. Its go-to-market is event- and publication-driven, with mission expansion governed by French public health regulation rather than competitive positioning.

Name

OMéDIT PACA-Corse

Legal name

Agence Régionale de Santé PACA – OMéDIT PACA-CORSE Direction des Politiques Régionales de Santé (DPRS)

Website

https://omeditpacacorse.fr

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

OMéDIT PACA-Corse is a French public health observatory under ARS PACA and ARS Corse that provides medication and medical-device guidance, training, and coordination to healthcare establishments, ESMS facilities, and professionals across the PACA and Corsica regions.

Ownership category

akta.pro rank

Headquarters

HQ city

Marseille

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Public Institutional Funding: As a public establishment (établissement public) under the Direction des Politiques Régionales de Santé (DPRS) of ARS PACA, OMéDIT PACA-Corse is funded through public institutional budgets. No commercial revenue generation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

OMéDIT PACA-Corse is a regional public health observatory under the French Agence Régionale de Santé (ARS) PACA and ARS Corse. It provides expertise, training, guidance documents, and coordination support to healthcare establishments and professionals on medication safety, medical device usage, pharmacoeconomics, clinical pharmacy, and therapeutic innovation across the PACA and Corsica regions. Its deliverables include newsletters, training modules, annual conferences, guidance fact sheets, expert reference systems (CEPPIM), and periodic flash information bulletins.

Product overview

OMéDIT PACA-Corse is an inter-regional public health observatory (Observatoire du Médicament, des Dispositifs Médicaux et de l'Innovation Thérapeutique) providing coordination, expertise, and support for healthcare professionals. It is not a software product company but rather a regional health authority structure placed under the Regional Health Agencies (ARS) of PACA and Corsica. Its offerings consist of professional resources including: the Newsletter OMéDIT (periodic publication), Formations modules (notably Conciliation Médicamenteuse), the annual JPCO clinical pharmacy conference series, the Web Série DMI educational video series, Fiches de Bon Usage guidance documents, the CEPPIM expert reference system, the Prix OMÉDIT award program, and Flash Infos bulletins. These resources collectively support drug and medical device safety, clinical pharmacy practices, and healthcare professional education across the region.

Differentiator

Problem solved

Functional benefit

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

14 partnerships are on record, tiered core, major, moderate and minor.

• ARS Corse (Agence Régionale de Santé Corse)coreStrategic or Co-development Partner · 1 January 2005OMéDIT PACA-Corse serves both ARS PACA and ARS Corse as an interregional structure. ARS Corse hosts the secondary site of the organization in Ajaccio.
• ARS PACA (Agence Régionale de Santé PACA)coreStrategic or Co-development Partner · 1 January 2000ARS PACA is the primary institutional parent of OMéDIT PACA-Corse. The organization is placed under the Direction des Politiques Régionales de Santé (DPRS) of ARS PACA. ARS PACA provides funding, mandate, and oversight for regional health product policy implementation.
• ANSM (Agence nationale de sécurité du médicament)majorStrategic or Co-development PartnerNational regulatory agency for medication safety. OMéDIT references ANSM guidelines and collaborates on medication safety initiatives across the region.
• HAS (Haute Autorité de Santé)majorStrategic or Co-development PartnerNational health authority setting quality and safety standards. OMéDIT supports implementation of HAS guidelines and certification requirements in regional healthcare establishments.
• SFPC (Société Française de Pharmacie Clinique)majorStrategic or Co-development PartnerProfessional society for clinical pharmacy. OMéDIT collaborates on clinical pharmacy events, training, and knowledge sharing. Jointly organizes pharmacy clinical congresses.
• CPIAS PACA (Centre d'Appui pour la Prévention des Infections Associées aux Soins)moderateStrategic or Co-development PartnerRegional infection prevention center. Collaborates with OMéDIT on healthcare safety initiatives and professional training.
• Reso InfectiomoderateStrategic or Co-development PartnerRegional network for infectious disease management. Partners with OMéDIT on infection prevention and antibiotic stewardship initiatives.
• OncoPACAmajorStrategic or Co-development PartnerRegional cancer care network. Co-organizes the annual Clinical Pharmacy in Oncology Days (JPCO) with OMéDIT and collaborates on cancer treatment quality initiatives.
• ANAP (Agence Nationale d'Appui à la Performance)moderateStrategic or Co-development PartnerNational agency supporting healthcare performance improvement. OMéDIT references ANAP tools and methodologies for healthcare establishment support.
• Santé Publique FrancemoderateStrategic or Co-development PartnerNational public health agency. Collaborates on public health initiatives including vaccination campaigns, COVID-19 response, and prevention programs.
• Assurance Maladie (Ameli)moderateStrategic or Co-development PartnerNational health insurance provider. OMéDIT references Ameli coding systems and collaborates on medication reimbursement policies and healthcare quality initiatives.
• ASIP SantémoderateTechnology or IntegrationNational agency for digital health systems. OMéDIT supports implementation of digital health tools including Mon Espace Santé and MSSanté secure messaging.
• URPS Pharmaciens PACAmoderateStrategic or Co-development PartnerRegional union of community pharmacists. Collaborates on city-hospital medication coordination and community pharmacy engagement.
• ESTS PACA-CorseminorStrategic or Co-development PartnerRegional health technology assessment body. Collaborates on evaluation of health products and innovation assessment.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• OMEDIT Normandie: Regional OMéDIT observatory for Normandy, operating under the same legal framework and providing comparable expert support to hospitals and ESMS on drug and medical device use.
• OMEDIT Hauts-de-France: Regional OMéDIT observatory for the Hauts-de-France region, comparable in scope (medication/medical device safety, CAQES support, professional training) and operating model.
• OMEDIT Grand Est: Regional OMéDIT observatory for the Grand Est region with comparable mission on medication/medical device best practices, clinical pharmacy training, and quality/safety support.
• OMEDIT Bretagne: Regional OMéDIT observatory for Brittany, offering parallel products (newsletters, Bon Usage documents, training) and serving analogous hospital and ESMS segments.
• OMEDIT Auvergne-Rhône-Alpes: Regional OMéDIT observatory for Auvergne-Rhône-Alpes, offering parallel guidance, training, and pharmacoeconomic expertise to healthcare establishments under the same French Public Health Code framework.
• OMEDIT Nouvelle-Aquitaine: Regional OMéDIT observatory covering the Nouvelle-Aquitaine region with the same scope on medication, medical devices and therapeutic innovation. Provides directly comparable services including training, CAQES support, and clinical pharmacy events.
• OMEDIT Occitanie: Regional OMéDIT observatory serving Occitanie, providing medication and medical device guidance, training programs, and quality/compliance support analogous to OMéDIT PACA-Corse.
• OMEDIT Île-de-France: Regional drug, medical device and therapeutic innovation observatory for the Île-de-France region. Operates the same statutory mandate under its local ARS, making it the closest functional peer in terms of mission, products (newsletters, training, guidance documents) and stakeholder base.

Broad incumbents

• Haute Autorité de Santé (HAS): National French health authority setting quality, safety, and certification standards. OMéDIT PACA-Corse explicitly references and supports implementation of HAS guidelines, making HAS the broader national incumbent shaping OMéDIT's mandate.
• RESOMEDIT: National network that federates the regional OMéDIT observatories, including OMéDIT PACA-Corse. Acts as the umbrella body for inter-regional coordination, shared methodology, and national representation, with broader scope but lower regional depth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/OmeditPacaCorse
• LinkedInlinkedin.com/company/om%C3%A9dit-paca-corse

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OMéDIT PACA-Corse